Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00842608 · ClinicalTrials.gov registry record · NA
Pharmacological Management of Delirium
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 551
- Enrollment target
NCT00842608: Completed NA study, sponsored by Indiana University.
NCT00842608 is a NA study that has completed, run by Indiana University. The registered enrollment target is 551 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00842608, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 551 participants
- Enrollment target
Study Summary
The purpose of this study is to develop and test the feasibility of using a specific pharmacological protocol to reduce delirium burden among older adults in the Intensive Care Unit (ICU). The study will test the efficacy of a pharmacological intervention in reducing delirium severity and duration as well as length of stay and mortality compared to usual care.
Interventions
- DRUG Haloperidol
- PROCEDURE Usual care
- BEHAVIORAL Reduced exposure to anticholinergics
- PROCEDURE Reduced exposure to benzodiazepines
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 551 participants |
| Start Date | 2009-02 |
| Est. Completion | 2015-07 |
| Phase | NA |
What the finished NCT00842608 record still lists
NCT00842608 is an interventional study that assigns participants to a tested intervention. The registered 551 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% lower).
The record links to 0 conditions, and to 4 interventions - of which Haloperidol is the first listed.
NCT00842608 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00842608 about?
NCT00842608 is a clinical study titled "Pharmacological Management of Delirium". The purpose of this study is to develop and test the feasibility of using a specific pharmacological protocol to reduce delirium burden among older adults in the Intensive Care Unit (ICU). The study will test the efficacy of a pharmacological intervention in reducing delirium severity and duration a...
What is the current status of trial NCT00842608?
This trial is currently completed. It is a NA study. The enrollment target is 551 participants. The study started on 2009-02. Estimated completion is 2015-07.
What interventions are being tested in trial NCT00842608?
The interventions under investigation include: Haloperidol (DRUG), Usual care (PROCEDURE), Reduced exposure to anticholinergics (BEHAVIORAL), Reduced exposure to benzodiazepines (PROCEDURE).
Who is sponsoring clinical trial NCT00842608?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00842608's enrollment target sits among peer trials
551 184th of 2000 higher than 1,817 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06217809 · 552 participants · NA
EmpowHer is Prevention Curriculum for Youth Ages 10-15 Years.
- NCT07146022 · 552 participants · Phase 3
Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
- NCT01852448 · 550 participants
Genetics of Insulin and Incretins in Cystic Fibrosis
- NCT02995252 · 550 participants
The HOPE Study: Characterizing Patients With Hepatitis B and C
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia